Growth Metrics

Organon (OGN) Cash from Investing Activities (2020 - 2026)

Organon has reported Cash from Investing Activities over the past 7 years, most recently at $386.0 million for Q1 2026.

  • For Q1 2026, Cash from Investing Activities rose 324.42% year-over-year to $386.0 million; the TTM value through Mar 2026 reached $168.0 million, up 128.52%, while the annual FY2025 figure was -$390.0 million, 23.98% up from the prior year.
  • Cash from Investing Activities for Q1 2026 was $386.0 million at Organon, up from -$65.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $386.0 million in Q1 2026 and troughed at -$296.0 million in Q4 2024.
  • A 5-year average of -$70.4 million and a median of -$70.0 million in 2023 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 265.43% in 2024 and later soared 324.42% in 2026.
  • Year by year, Cash from Investing Activities stood at -$61.0 million in 2022, then crashed by 32.79% to -$81.0 million in 2023, then plummeted by 265.43% to -$296.0 million in 2024, then surged by 78.04% to -$65.0 million in 2025, then surged by 693.85% to $386.0 million in 2026.
  • Business Quant data shows Cash from Investing Activities for OGN at $386.0 million in Q1 2026, -$65.0 million in Q4 2025, and -$115.0 million in Q3 2025.